HLF and acute myeloid leukemia: A non-randomized clinical trial on a small group of patients (n = 14) with acute myelogenous leukemia (AML), undergoing chemotherapy, showed a protective effect of oral hLF, administered as prophylaxis, to protect against infections [133].